Heterogeneity of T-cell clones infiltrating primary malignant melanomas

Journal of Investigative Dermatology

Volumn 126, Issue 2, 2006, Pages 393-398

  Yazdi, Amir S ^a,b   Morstedt, Kathrin ^b   Puchta, Ursula ^b   Ghoreschi, Kamran ^a   Flaig, Michael J ^b   Rocken, Martin ^a   Sander, Christian A ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c AK St Georg ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ARTICLE; BIOPSY; CELL HETEROGENEITY; CELL INFILTRATION; CLONING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LYMPHOCYTE SUBPOPULATION; MELANOMA; METASTASIS; MICRODISSECTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

CLONE CELLS; DNA, NEOPLASM; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; LASERS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MICRODISSECTION; NEOPLASM STAGING; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 33644648862     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700082     Document Type: Article

References (23)

1. Anastassiou G, Rebmann V, Wagner S, Bornfeld N, Grosse-Wilde H (2003) Expression of classic and nonclassic HLA class I antigens in uveal melanoma. Invest Ophthalmol Vis Sci 44:2016-9
2. Cole WH (1976) Spontaneous regression of cancer and the importance of finding its cause. Natl Cancer Inst Monogr 44:5-9
3. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ et al. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850-4
4. Egeter O, Mocikat R, Ghoreschi K, Dieckmann A, Rocken M (2000) Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice. Cancer Res 60:1515-20
5. Ferradini L, Mackensen A, Genevee C, Bosq J, Duvillard P, Avril MF et al. (1993) Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion. J Clin Invest 91:1183-90
6. Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, Vigneron N et al. (2005) High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J Exp Med 201:241-8
7. Graf A, Kaudewitz P, Simon M, Kind P, Sander CA (1996) Nachweis von Klonalität in kutanen T-Zellymphomen mittels der Polymerasekettenreaktion. Pathologe 17:446-50
8. Greenberg PD (1991) Adoptive T cell therapy of tumors: mechanisms operative in the recognition, and elimination of tumor cells. Adv Immunol 49:281-355
9. Holm N, Flaig MJ, Yazdi AS, Sander CA (2002) The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates. J Cutan Pathol 29:447-52
10. Lowes MA, Bishop GA, Crotty K, Barnetson RS, Halliday GM (1997) T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J Invest Dermatol 108:914-9
11. Lurquin C, Lethe B, De Plaen E, Corbiere V, Theate I, van Baren N et al. (2005) Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen. J Exp Med 201:249-57
12. Mocikat R, Braumuller H, Gumy A, Egeter O, Ziegler H, Reusch U et al. (2003) Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8T cell responses. Immunity 19:561-9
13. Romero P, Dunbar PR, Valmori D, Pittet M, Ogg GS, Rimoldi D et al. (1998) Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 188:1641-50
14. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA et al. (1985) Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-4
15. Salvi S, Segalla F, Rao S, Arienti F, Sartori M, Bratina G et al. (1995) Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res 55:3374-9
16. Schuhmann K, Flaig MJ, Bertsch HP, Sander CA (1999) Klonalitä tsanalyse kutaner Pseudolymphome. Akt Dermatol 25:99-101
17. Shibata DK, Arnheim N, Martin WJ (1988) Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 167:225-30
18. Thor Straten P, Becker JC, Seremet T, Brocker EB, Zeuthen J (1996) Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J Clin Invest 98:279-84
19. Thor Straten P, Guldberg P, Gronbaek K, Hansen MR, Kirkin AF, Seremet T et al. (1999) In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes. J Immunol 163:443-7
20. Thor Straten P, Guldberg P, Moerch U, Becker JC (2000) Anti-melanocyte T cell responses - methodology versus biology. J Invest Dermatol 114:738-9
21. Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES et al. (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188:51-64
22. Yazdi AS, Puchta U, Thaller E, Flaig MJ, Sander CA (2003) Rapid detection of T-cell receptor γ gene rearrangement in cutaneous T cell lymphoma. J Cutan Pathol 30:486-91
23. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M et al. (2000) Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 192:1637-44